Scarica l'app Stockscreener
165.89
4.21%
6.70
Charles River Laboratories International Inc Borsa (CRL) Ultime notizie
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Why is Charles River (CRL) down 6.8% since last earnings report? - MSN
Charles River Laboratories stock: Is CRL underperforming the healthcare sector? - MSN
Charles River Labs stock faces technical shift to sideways amid mixed signals and 2026 guidance - AD HOC NEWS
Charles River Laboratories Experiences Evaluation Revision Amid Mixed Market Signals - Markets Mojo
Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector? - Yahoo Finance
Could Charles River (CRL) Using Locus Cell Tie-Up to Reframe Its Asia-Pacific Growth Strategy? - simplywall.st
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MSN
10,284 Shares in Charles River Laboratories International, Inc. $CRL Purchased by Oliver Luxxe Assets LLC - MarketBeat
JPMorgan Chase & Co. Raises Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat
Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report? - Yahoo Finance
Confluence Investment Management LLC Has $21.07 Million Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
FDA issues guidance on replacing animal testing (CRL:NYSE) - Seeking Alpha
Charles River Laboratories International, Inc. (NYSE:CRL) Sees Significant Increase in Short Interest - MarketBeat
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Charles River Laboratories International (CRL) faces biotech R&D spending headwinds - MSN
National Bank of Canada FI Grows Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River announces divestitures, updates guidance - MSN
Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors - MarketWatch
CRL,PBE Volatility & Greeks - Finviz
Charles River Laboratories International, Inc. $CRL Holdings Reduced by Iron Triangle Partners LP - MarketBeat
Gotham Asset Management LLC Acquires 46,594 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International, Inc. Common Stock (NY: CRL - The Chronicle-Journal
Charles River Laboratories Hits Day Low of $151.91 Amid Price Pressure - Markets Mojo
Earnest Partners LLC Raises Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Algert Global LLC Buys 39,586 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories Stock (ISIN: US1591881009) Surges on Earnings Beat and $1B Buyback Amid R - AD HOC NEWS
A Look At Charles River Laboratories (CRL) Valuation After Its Earnings Beat And New US$1b Buyback - simplywall.st
Are Charles River’s New Advanced Therapy Deals Quietly Rewriting Its Drug-Development Moat Story (CRL)? - Sahm
Charles River announces strategic review including 'examination of various alternatives' - MSN
Charles River Laboratories International, Inc. $CRL Position Lessened by Integral Health Asset Management LLC - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Meridiem Capital Partners LP Sells 49,567 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Zacks Research Issues Negative Outlook for CRL Earnings - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Has $28.25 Million Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
0.19%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):